First China Pharmaceutical Group Inc's Competitiveness
A competitive positioning analysis and financial ratio benchmarking of First China Pharmaceutical Group Inc (FCPG) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.
Key Findings: First China Pharmaceutical Group Inc vs Its Competitors
- TTM: Trailing 12-month revenue of 58M vs -M combined for tracked competitors (100.0% combined share).
- Trending: Latest-quarter revenue run-rate is accelerating (+20.2% annualized vs trailing 12 months).
- Peer revenue share: First China Pharmaceutical Group Inc accounted for 100.0% of combined revenue among its tracked peer group, up from 100.0% a year earlier.
Every figure above is sourced and cited in detail further down this page (Market Structure, Profitability & Cost Structure, Productivity vs Peers).
FCPG Sales vs. its Competitors, 2012
First China Pharmaceutical Group Inc generated 100.00 % of the combined sales of its peer group, up from 100.00 % a year earlier.
For context: the Healthcare Facilities industry grew revenue 14.8% year over year, combined, vs 22.2% for First China Pharmaceutical Group Inc. First China Pharmaceutical Group Inc's share of combined industry revenue moved from 0.01% to 0.01%, a gain of 0.00 percentage points.